针对mTOR的基于植物酸的纳米药物抑制了代谢功能障碍相关的脂肪肝炎治疗的脂质生成和免疫反应
Fenghua Xu1,2, Shoujie Zhao3, Yejing Zhu1
1State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and Xijing Hospital of Digestive Diseases, Air Force Medical University, Xi'an, Shaanxi 710032, China.
Life metabolism
|January 28, 2025
概括
一种新的-酸 (CePA) 纳米复合物通过抑制mTOR信号传递,有效地治疗与代谢功能障碍相关的脂肪肝炎 (MASH). 这种有针对性的方法可以减少肝炎和脂肪积累,为MASH提供了有前途的治疗方法.
科学领域:
- 肝病学和代谢疾病
- 纳米医学和药物输送
背景情况:
- 代谢功能障碍相关的脂肪肝炎 (MASH) 是一种普遍的慢性肝病,由代谢障碍和炎症驱动.
- 猛素 (mTOR) 信号的哺乳动物点通过促进脂质生成和改变免疫微环境,加剧了MASH.
- 目前的mTOR抑制剂由于特异性和副作用不佳而面临限制,需要新的治疗策略.
研究的目的:
- 开发和评估一种用于MASH治疗的新型-酸 (CePA) 纳米复合物.
- 研究CePA抑制mTOR信号传递和缓解MASH进展的机制.
主要方法:
- 一个-酸 (CePA) 纳米复合物被合成,利用酸的富含酸的结构和的基化酶活性.
- 研究了CePA对mTOR酸化 (S2448) 的干预及其对mTOR-SREBP1轴的影响.
- 在体内实验中,使用高脂肪饮食诱导的MASH小鼠模型进行了实验,以评估CePA的治疗疗效.
主要成果:
- CePA通过酸盐组占用有效抑制了mTOR S2448酸化,破坏了炎症反应和mTOR-SREBP1通路.
- 在体内研究表明,CePA显著缓解了MASH的进展,并减少了小鼠的肝脏脂肪积累.
- 机理学研究证实了CePA的肝脏向的mTOR抑制功能.
结论:
- 开发的CePA纳米复合物显示出作为MASH的向治疗剂的巨大潜力.
- CePA抑制mTOR信号传递的能力为治疗MASH和其他mTOR相关的肝病提供了有前途的策略.
- 这项研究强调了将天然化合物与金属离子结合起来,用于向疾病管理的治疗潜力.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Electron Transport Chain: Complex I and II
10.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
10.7K


